Based on 6 analysts giving stock ratings to Health Catalyst Inc in the past month.
In the current month, HCAT has received 0 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. HCAT average Analyst price target in the last month is 1.825.
Based on analysts' estimates, HCAT EPS is projected to reach -0.054 in FY2026Q3, following reported EPS of -0.548 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.55, while Health Catalyst IncHCAT's earnings per share (EPS) for the previous quarter was USD -1.53. EPS for the next quarter is expected at USD -0.05.